Phibro Animal Health (PAHC) Net Cash Flow Growth (1y) (2014 - 2026)
Phibro Animal Health (PAHC) Net Cash Flow Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.51 Bn | 87.64 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 36.00 Bn | 32.26 Bn | 1.97 Bn | 112.26% |
| 3 | Zoetis | 32.61 Bn | 30.67 Bn | 1.62 Bn | -44.11% |
| 4 | Takeda Pharmaceutical | 27.49 Bn | 23.43 Bn | 4.39 Bn | 209.30% |
| 5 | United Therapeutics | 23.05 Bn | 20.90 Bn | 648.10 Mn | -236.85% |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - | - |
| 7 | Viatris | 20.26 Bn | 18.46 Bn | 1.16 Bn | 13,485.29% |
| 8 | Neurocrine Biosciences | 17.79 Bn | 16.47 Bn | 800.70 Mn | -1,047.81% |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | -1,020.00% |
| 10 | Phibro Animal Health | 1.42 Bn | 1.34 Bn | 125.68 Mn | 60.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60.38% |
| Dec 31, 2025 | -188.84% |
| Sep 30, 2025 | 123.70% |
| Jun 30, 2025 | -69.33% |
| Mar 31, 2025 | -142.09% |
| Dec 31, 2024 | 336.30% |
| Sep 30, 2024 | -1,010.17% |
| Jun 30, 2024 | 482.37% |
| Mar 31, 2024 | 155.68% |
| Dec 31, 2023 | 6.70% |
| Sep 30, 2023 | -13.31% |
| Jun 30, 2023 | -18.06% |
| Mar 31, 2023 | -584.02% |
| Dec 31, 2022 | -137.13% |
| Sep 30, 2022 | 128.81% |
| Jun 30, 2022 | 755.51% |
| Mar 31, 2022 | -56.82% |
| Dec 31, 2021 | 741.43% |
| Sep 30, 2021 | -56.60% |
| Jun 30, 2021 | -94.46% |